ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
abrdn Life Sciences Investors

abrdn Life Sciences Investors (HQL)

16,92
-0,35
(-2,03%)
Fermé 06 Juin 10:00PM
17,00
0,08
(0,47%)
Après les heures de négociation: 1:56AM

abrdn Life Sciences Investors (HQL) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
17,00
( -1,56% )
Prix Achat
-
Prix Vente
-
Volume échangé
127 018
16,5901 Fourchette du Jour 17,285
12,34 Plage de 52 semaines 18,46
Cap du marché
Clôture Veille
17,27
Ouverture
17,25
Dernière Transaction
291
@
16.92
Dernière heure de transaction
Volume financier
US$ 2 167 021
VWAP
17,0607
Volume moyen (3 m)
US$ 107 071
Actions en circulation
30 408 047
Rendement du Dividende (LTM)
1,82 (11,00%)
Ratio Cours sur Bénéfices
6,18
Bénéfice par action (BPA)
2,89
Chiffre d'affairess (LTM)
1,94M
Bénéfice net (LTM)
85,59M

À propos de abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics,... Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Show more

Secteur
Finance
Industrie
Asset Management Services
Siège social
Philadelphia, United States
Fondé
1992
abrdn Life Sciences Investors est coté dans le secteur Finance de la New York Stock Exchange avec le ticker HQL. Le dernier cours de clôture d'abrdn Life Sciences Inve... était de US$17,27. Au cours de la dernière année, les actions de abrdn Life Sciences Inve... ont été négociées dans une fourchette de prix de US$ 12,34 à US$ 18,46.

abrdn Life Sciences Inve... compte actuellement 30 408 047 actions en circulation. La capitalisation boursière d'abrdn Life Sciences Inve... est de US$516,94 million. abrdn Life Sciences Inve... a un ratio cours/bénéfice (ratio PE) de 6.18.

HQL Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.76-4.2792792792817.7617.9116.6410101717.29671331CS
4-1.03-5.712701053818.0318.4616.4410594917.60269509CS
120.352.102102102116.6518.4615.819410163517.27548166CS
26-0.29-1.6772700983217.2918.4615.6611790217.03751009CS
524.4335.242641209212.5718.4612.3413369515.96626671CS
1563.42513.618.4610.550111591014.41617728CS
260-3.04-15.169660678620.0422.710.550110122615.07215636CS

HQL - Frequently Asked Questions (FAQ)

What is the current abrdn Life Sciences Investors share price?
The current share price of abrdn Life Sciences Investors is US$ 17,00
How many abrdn Life Sciences Investors shares are in issue?
abrdn Life Sciences Investors has 30 408 047 shares in issue
What is the market cap of abrdn Life Sciences Investors?
The market capitalisation of abrdn Life Sciences Investors is USD 516,94M
What is the 1 year trading range for abrdn Life Sciences Investors share price?
abrdn Life Sciences Investors has traded in the range of US$ 12,34 to US$ 18,46 during the past year
What is the PE ratio of abrdn Life Sciences Investors?
The price to earnings ratio of abrdn Life Sciences Investors is 6,18
What is the cash to sales ratio of abrdn Life Sciences Investors?
The cash to sales ratio of abrdn Life Sciences Investors is 280,17
What is the registered address of abrdn Life Sciences Investors?
The registered address for abrdn Life Sciences Investors is 1900 Market Street, Philadelphia, Pennsylvania, 19103
Which industry sector does abrdn Life Sciences Investors operate in?
abrdn Life Sciences Investors operates in the Asset Management Services sector

HQL Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion